ROSSARI

Rossari Biotech Limited

Specialty chemicals and biosolutions for home care, textiles and animal health

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

rossari.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹454.65
Market cap
2,519 Cr
Stock P/E
16.5
P/B
1.79
Dividend yield
0.1%
ROE (FY26)
11.2%
ROCE (FY26)
13.3%
Operating margin (FY26)
8.6%
Debt / equity (FY26)
0.31
OCF / EBITDA (FY26)
22.8%
OCF / EBITDA (3Y)
30.7%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Rossari Biotech makes specialty chemicals and formulations for home and personal care, textile and animal health and nutrition customers, selling in India and in export markets.

Company snapshot

34thBy market cap

Ranked among 68 companies in Specialty Chemicals.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Sales464 Cr473 Cr490 Cr498 Cr513 Cr580 Cr544 Cr586 Cr582 Cr685 Cr697 Cr698 Cr
Operating expenses (approx.)400 Cr409 Cr425 Cr432 Cr448 Cr510 Cr476 Cr514 Cr513 Cr608 Cr617 Cr611 Cr
EBITDA64 Cr64 Cr65 Cr66 Cr65 Cr69 Cr68 Cr72 Cr69 Cr77 Cr81 Cr87 Cr
OPM %13.7%13.5%13.3%13.2%12.6%12.0%12.5%12.3%11.8%11.3%11.6%12.5%
Other income4 Cr0.39 Cr0.95 Cr0.72 Cr0.55 Cr2 Cr1 Cr2 Cr0.51 Cr19 Cr3 Cr0.60 Cr
Interest4 Cr3 Cr4 Cr4 Cr5 Cr6 Cr6 Cr6 Cr8 Cr9 Cr11 Cr9 Cr
Depreciation15 Cr16 Cr15 Cr15 Cr18 Cr18 Cr18 Cr18 Cr20 Cr24 Cr26 Cr30 Cr
Profit before tax48 Cr46 Cr47 Cr48 Cr42 Cr48 Cr46 Cr50 Cr43 Cr64 Cr48 Cr49 Cr
Tax %28.0%25.1%25.7%26.6%25.2%27.8%27.1%25.8%22.9%28.4%26.4%21.0%
Net profit34 Cr34 Cr35 Cr35 Cr32 Cr34 Cr34 Cr37 Cr33 Cr46 Cr35 Cr39 Cr
EPS (₹)₹6.23₹6.18₹6.32₹6.39₹5.73₹6.22₹6.07₹6.66₹5.92₹8.30₹6.34₹7.02

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales516 Cr600 Cr709 Cr1,483 Cr1,656 Cr1,831 Cr2,080 Cr2,396 CrSign in free for the trailing twelve months
Operating expenses (approx.)439 Cr495 Cr586 Cr1,300 Cr1,433 Cr1,581 Cr1,815 Cr2,110 CrSign in free for the trailing twelve months
EBITDA78 Cr105 Cr123 Cr183 Cr223 Cr250 Cr265 Cr286 CrSign in free for the trailing twelve months
OPM %15.0%17.5%17.3%12.4%13.5%13.6%12.7%11.9%Sign in free for the trailing twelve months
Other income0.91 Cr4 Cr9 Cr12 Cr5 Cr7 Cr4 Cr22 CrSign in free for the trailing twelve months
Interest3 Cr4 Cr3 Cr13 Cr22 Cr19 Cr18 Cr29 CrSign in free for the trailing twelve months
Depreciation12 Cr17 Cr23 Cr48 Cr63 Cr60 Cr67 Cr79 CrSign in free for the trailing twelve months
Profit before tax63 Cr88 Cr107 Cr136 Cr144 Cr178 Cr185 Cr203 CrSign in free for the trailing twelve months
Tax %27.9%25.7%25.1%28.3%25.6%26.4%26.4%26.3%Sign in free for the trailing twelve months
Net profit46 Cr65 Cr80 Cr98 Cr107 Cr131 Cr136 Cr149 CrSign in free for the trailing twelve months
EPS (₹)₹9.44₹13.42₹15.56₹17.81₹19.46₹23.67₹24.66₹26.95Sign in free for the trailing twelve months
Dividend payout %——3.2%2.8%2.6%2.1%2.0%1.9%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital4 Cr10 Cr10 Cr11 Cr11 Cr11 Cr11 Cr11 Cr
Reserves119 Cr277 Cr398 Cr794 Cr904 Cr1,037 Cr1,174 Cr1,322 Cr
Borrowings4 Cr61 Cr—8 Cr74 Cr106 Cr188 Cr408 Cr
Other liabilities122 Cr124 Cr153 Cr443 Cr378 Cr419 Cr523 Cr547 Cr
Total liabilities250 Cr472 Cr561 Cr1,257 Cr1,368 Cr1,572 Cr1,896 Cr2,289 Cr
Fixed assets (net)68 Cr82 Cr168 Cr347 Cr314 Cr315 Cr354 Cr561 Cr
CWIP3 Cr22 Cr0.32 Cr1 Cr13 Cr47 Cr140 Cr173 Cr
Investments—18 Cr0 Cr36 Cr51 Cr63 Cr84 Cr62 Cr
Loans & advances——1 Cr1 Cr0.29 Cr0.70 Cr1 Cr1 Cr
Inventories55 Cr58 Cr95 Cr190 Cr188 Cr282 Cr355 Cr405 Cr
Trade receivables86 Cr94 Cr144 Cr305 Cr354 Cr425 Cr475 Cr557 Cr
Cash & bank6 Cr29 Cr15 Cr37 Cr70 Cr25 Cr44 Cr75 Cr
Other assets32 Cr169 Cr137 Cr339 Cr377 Cr414 Cr444 Cr454 Cr
Total assets250 Cr472 Cr561 Cr1,257 Cr1,368 Cr1,572 Cr1,896 Cr2,289 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity71 Cr55 Cr48 Cr29 Cr152 Cr43 Cr137 Cr65 Cr
Cash from investing-36 Cr-190 Cr-37 Cr-299 Cr-181 Cr-103 Cr-184 Cr-219 Cr
Cash from financing-29 Cr157 Cr-25 Cr292 Cr61 Cr16 Cr65 Cr186 Cr
Net cash flow6 Cr21 Cr-14 Cr22 Cr32 Cr-44 Cr19 Cr31 Cr
Free cash flow (OCF − Capex)27 Cr-21 Cr-10 Cr-9 Cr120 Cr-88 Cr-21 Cr-200 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %51.9%26.3%26.9%18.3%16.8%17.1%14.8%13.3%
ROE %36.9%22.8%19.6%12.1%11.7%12.5%11.5%11.2%
Debtor days6157747578858385
Inventory days5657807164849992
Days payable109961107062658073
Cash conversion cycle819447679104102103
OCF / EBITDA %91.7%52.3%38.8%16.0%68.3%17.3%51.8%22.8%
OCF / EBITDA % (3 years)——56.9%32.1%43.3%34.3%45.1%30.7%
Debt / equity0.030.21—0.010.080.100.160.31
Current ratio1.312.192.362.072.081.991.941.57
Net debt / EBITDA-0.020.30-0.12-0.160.020.320.541.16